Ron Zwanziger, a strategic visionary and entrepreneur, is the CEO of LumiraDx, which he co-founded in 2014. He previously founded and led numerous successful diagnostic firms, including Alere, Inverness Medical Technology (which was acquired by Johnson & Johnson in 2001), and MediSense, the first company to introduce an electrochemical glucose sector. He currently serves on the Board of Directors of several private companies.
Date | Company Name | Round | Money Raised | Industry | |
---|---|---|---|---|---|
Mar 1, 2022 | LumiraDx | Post-IPO Debt | $56.50M | Health Care | Detail |